NeuracleGenetics

AAV 벡터 기반 유전자치료제 연구개발

General Information
Company Name
NeuracleGenetics
Founded Year
2018
Location (Offices)
Korea South +1
Founders / Decision Makers
Number of Employees
8
Industries
Biotechnology, Pharmaceutical
Funding Stage
Series B
Social Media

NeuracleGenetics - Company Profile

Newracle Genetics received a KRW30.00B Series B investment on 03 June 2021 from a consortium of investors including Partners Investment, DA Value Investment, DAYLI Partners, Ryukyung PSG, Seven Tree Equity Partners, Quad Asset Management, Widwin Investment, Ulmus Investment, Saehan Startup Investment, and SV Investment Corp. The company, founded in 2018, operates in the Biotechnology and Pharmaceutical industries. Although specific details about its headquarters, slogan, and description are not available, the recent significant investment signifies strong potential in Newracle Genetics' innovative biotech and pharmaceutical ventures.

Funding Rounds & Investors of NeuracleGenetics (1)

View All
Funding Stage Amount No. Investors Investors Date
Series B KRW30.00B 10
Partners Investment, investor in NeuracleGenetics's Series B round DA Value Investment, investor in NeuracleGenetics's Series B round DAYLI Partners, investor in NeuracleGenetics's Series B round Ryukyung PSG, investor in NeuracleGenetics's Series B round Seven Tree Equity Partners, investor in NeuracleGenetics's Series B round SV Investment, investor in NeuracleGenetics's Series B round Quad Asset Management, investor in NeuracleGenetics's Series B round Widwin Investment, investor in NeuracleGenetics's Series B round Ulmus Investment, investor in NeuracleGenetics's Series B round
Saehan Startup Investment 		03 Jun 2021

Latest News of NeuracleGenetics

View All

No recent news or press coverage available for NeuracleGenetics.

Similar Companies to NeuracleGenetics

View All
Avirmax, Inc. - Similar company to NeuracleGenetics
Avirmax, Inc. Developing rAAV mediated gene therapy Safe, Effective, Affordable and Accessible
StrideBio, Inc - Similar company to NeuracleGenetics
StrideBio, Inc The next evolution in gene therapy
Oxford Biomedica - Similar company to NeuracleGenetics
Oxford Biomedica A quality and innovation-led CDMO in cell and gene therapy
VectorY - Similar company to NeuracleGenetics
VectorY VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.
Genprex, Inc. - Similar company to NeuracleGenetics
Genprex, Inc. Genprex is a gene therapy company focused on developing life-changing technologies for patients with cancer & diabetes.